Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Latorzeff

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 17, 2021
[The role of radiotherapy to the primary tumor and metastases in patients with oligometastatic prostate cancer]T Le Roy, D Baron, B Vandendorpe, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2014
[Postoperative radiotherapy of prostate cancer]S Guérif, I Latorzeff, J-L Lagrange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2016
[Prognostic factors of hyperbaric oxygen therapy in hemorrhagic radiation cystitis]M Bouaziz, M Genestal, G Perez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2019
[Treatment of oligometastatic or oligoprogression cancer]C Bourgier, I Latorzeff, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2013
[Hypofractionated radiotherapy in prostate cancer]S Supiot, G Créhange, I Latorzeff, et al.
Clinical and Translational Radiation Oncology|April 4, 2024
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLibJ Chamois, A L Septans, B Schipman, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 27, 2021
External radiotherapy for prostatic cancersR de Crevoisier, S Supiot, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 15, 2012
[Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy]J-P Gérard, B Aubert, I Buchheit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2022
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFITK Zhou, M Renouf, G Perrocheau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Radiosurgery for brain arteriovenous malformations]I Latorzeff, M Schlienger, J Sabatier, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 17, 2021
[The role of radiotherapy to the primary tumor and metastases in patients with oligometastatic prostate cancer]T Le Roy, D Baron, B Vandendorpe, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2014
[Postoperative radiotherapy of prostate cancer]S Guérif, I Latorzeff, J-L Lagrange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2016
[Prognostic factors of hyperbaric oxygen therapy in hemorrhagic radiation cystitis]M Bouaziz, M Genestal, G Perez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2019
[Treatment of oligometastatic or oligoprogression cancer]C Bourgier, I Latorzeff, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2013
[Hypofractionated radiotherapy in prostate cancer]S Supiot, G Créhange, I Latorzeff, et al.
Clinical and Translational Radiation Oncology|April 4, 2024
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLibJ Chamois, A L Septans, B Schipman, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 27, 2021
External radiotherapy for prostatic cancersR de Crevoisier, S Supiot, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 15, 2012
[Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy]J-P Gérard, B Aubert, I Buchheit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2022
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFITK Zhou, M Renouf, G Perrocheau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Radiosurgery for brain arteriovenous malformations]I Latorzeff, M Schlienger, J Sabatier, et al.
Pageof 8